ORAGENICS, INC. Interest Expense, Other
ORAGENICS, INC. (OGEN) reported Interest Expense, Other of $3.88 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2020-11-10
- ORAGENICS, INC. interest expense, other for the quarter ending 2020-09-30 was $3.88K, a 55.34% increase year-over-year.
- ORAGENICS, INC. interest expense, other for the quarter ending 2020-06-30 was $885.00, a 20.74% increase year-over-year.
- ORAGENICS, INC. interest expense, other for the quarter ending 2020-03-31 was $1.71K, a 31.69% increase year-over-year.
- ORAGENICS, INC. interest expense, other for the quarter ending 2019-12-31 was $2.77K.
- ORAGENICS, INC. interest expense, other for fiscal 2019 was $7.30K, a 26.17% increase from fiscal 2018.
- ORAGENICS, INC. interest expense, other for fiscal 2018 was $5.79K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2020-09-30 | $3.88K 10-Q · filed 2020-11-10 | $4.77K derived: sum of 2 quarters · filed 2020-11-10 | $6.48K 10-Q · filed 2020-11-10 | $9.25K derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | $885.00 10-Q · filed 2020-08-14 | $2.59K 10-Q · filed 2020-08-14 | $5.36K derived: sum of 3 quarters · filed 2020-08-14 | $7.86K derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-03-31 | $1.71K 10-Q · filed 2020-05-15 | $4.48K derived: sum of 2 quarters · filed 2020-05-15 | $6.98K derived: sum of 3 quarters · filed 2020-11-10 | $7.71K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-12-31 | $2.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $5.27K derived: sum of 2 quarters · filed 2020-11-10 | $6.00K derived: sum of 3 quarters · filed 2020-11-10 | $7.30K 10-K · filed 2020-03-04 |
| 2019-09-30 | $2.50K 10-Q · filed 2020-11-10 | $3.23K derived: sum of 2 quarters · filed 2020-11-10 | $4.53K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $733.00 10-Q · filed 2020-08-14 | $2.03K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $1.30K 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | $5.79K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |